Aclaris Therapeutics, Inc. (ACRS)
NASDAQ: ACRS · Real-Time Price · USD
4.220
-0.190 (-4.31%)
At close: Apr 28, 2026, 4:00 PM EDT
4.220
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:00 PM EDT
Aclaris Therapeutics Market Cap
Aclaris Therapeutics has a market cap or net worth of $586.56 million as of April 28, 2026. Its market cap has increased by 403.26% in one year.
Market Cap
586.56M
Enterprise Value
441.48M
1-Year Change
403.26%
Ranking
Category
Stock Price
$4.22
Market Cap Chart
Since October 7, 2015, Aclaris Therapeutics's market cap has increased from $214.45M to $586.56M, an increase of 173.51%. That is a compound annual growth rate of 10.00%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| First Tracks Biotherapeutics | 631.04M |
| Absci | 602.90M |
| Zevra Therapeutics | 595.88M |
| Adlai Nortye | 592.00M |
| ProKidney | 585.80M |
| Shattuck Labs | 585.00M |
| CorMedix | 581.94M |
| Prothena Corporation | 578.70M |